Hochschulschrift
A two-chain chimeric antigen receptor (CAR) scaffold recruits endogenous CD3 for superior T-cell function
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
113 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Literaturverzeichnis Seite 101-108
Enthält deutsche und englische Zusammenfassung
Im Titel ist "3" tiefgestellt
Johannes Gutenberg-Universität Mainz, Dissertation, 2019
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wann)
-
[2019]
- Urheber
- Beteiligte Personen und Organisationen
-
Johannes Gutenberg-Universität Mainz
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:15 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Birtel, Matthias
- Johannes Gutenberg-Universität Mainz
Entstanden
- [2019]
Ähnliche Objekte (12)
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry-species conversion in CD3 systems
Optimization of chimeric antigen receptor (CAR) therapy
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry-species conversion in CD3 systems
Optimization of chimeric antigen receptor (CAR) therapy
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry-species conversion in CD3 systems